Schedule 13D ownership disclosure

PHARMACYTE BIOTECH INC

Security class unavailable · CUSIP: 71715X104

Event date: 2020-06-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001753926-20-000215
Form type
SC 13D/A
Filer
Montazeri Nima
CIK
CIK 1811031
Filed
Jul 29, 2020
Reporting period
Jun 19, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub